- Open
- 1.77
- High
- 1.81
- Low
- 1.72
- Close
- 1.78
- Change
- -0.07 (-4.23%)
- Volume
- 2,859,194
⌘K
| 16 Oct 2025 | 07:00:09 | Appointments: Interim CEO and senior board advisor |
| 8 Oct 2025 | 07:00:10 | Strategy Update |
| 29 Sept 2025 | 07:00:18 | Presentation of Data on Glioblastoma |
| 12 Sept 2025 | 07:00:18 | Board Changes |
ANGLE is a top-tier liquid biopsy firm that offers end-to-end solutions for sample analysis. The company's cutting-edge technologies, which are protected by patents, include a method for capturing circulating tumor cells (CTCs) and a downstream analysis system that enables cost-effective, highly multiplexed analysis of nucleic acids and proteins.
| 16 Oct 2025 | 07:00:09 | Appointments: Interim CEO and senior board advisor |
| 8 Oct 2025 | 07:00:10 | Strategy Update |
| 29 Sept 2025 | 07:00:18 | Presentation of Data on Glioblastoma |
| 12 Sept 2025 | 07:00:18 | Board Changes |
ANGLE is a top-tier liquid biopsy firm that offers end-to-end solutions for sample analysis. The company's cutting-edge technologies, which are protected by patents, include a method for capturing circulating tumor cells (CTCs) and a downstream analysis system that enables cost-effective, highly multiplexed analysis of nucleic acids and proteins.
| 9 Sept 2025 |
| 07:01:00 |
| Interim Results |
| 16 May 2026 |
| CelLBxHealth, Caledonia Mining, Rome Resources, European Green Transition, International Biotechnology Trust, Pantheon International - Small Cap Week in Review |
| 9 Sept 2025 |
| 07:01:00 |
| Interim Results |
| 16 May 2026 |
| CelLBxHealth, Caledonia Mining, Rome Resources, European Green Transition, International Biotechnology Trust, Pantheon International - Small Cap Week in Review |
